| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |